SO
51
-6
XRAY
22
2
VRTX
43
-4
LOW
46
-2
HON
58
3
BMY
43
-3
PNW
60
-6
MSI
60
2
MTB
56
-3
IRM
63
-2
NEE
47
-5
TXT
53
3
CMI
47
-2
IR
55
-6
SYY
52
11
CAH
47
15
VMC
62
-7
DUK
37
-3
D
38
-2
CMS
54
-4
SO
51
-6
XRAY
22
2
VRTX
43
-4
LOW
46
-2
HON
58
3
BMY
43
-3
PNW
60
-6
MSI
60
2
MTB
56
-3
IRM
63
-2
NEE
47
-5
TXT
53
3
CMI
47
-2
IR
55
-6
SYY
52
11
CAH
47
15
VMC
62
-7
DUK
37
-3
D
38
-2
CMS
54
-4
Financhill
Back

IDEXX Laboratories Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
39

IDXX
IDEXX Laboratories

Last Price:
415.22
Seasonality Move:
6.37%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

IDEXX Laboratories Price Quote

$415.22
-2.06 (-0.49%)
(Updated: November 4, 2024 at 3:50 PM ET)

IDEXX Laboratories Key Stats

Sell
39
IDEXX Laboratories (IDXX) is a Sell
Day range:
$408.58 - $422.09
52-week range:
$404.74 - $583.39
Dividend yield:
0%
P/E ratio:
41.48
P/S ratio:
9.07
P/B ratio:
21.12%
Volume:
916.1K
Avg. volume:
586K
1-year change:
5.55%
Market cap:
$34.2B
Revenue:
$3.7B
EPS:
$10.37

How Much Does IDEXX Laboratories Make?

Is IDEXX Laboratories Growing As A Company?

  • What Is IDEXX Laboratories's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.07%
  • What Is IDEXX Laboratories's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.11%

IDEXX Laboratories Stock Price Performance

What Is IDEXX Laboratories 52-Week High & Low?

IDEXX Laboratories Price To Free Cash Flow

Is It Risky To Buy IDEXX Laboratories?

  • How Much Debt Does IDEXX Laboratories Have?
    Total long term debt quarterly is $873.9M
  • How Much Cash Does IDEXX Laboratories Have?
    Cash and short term investments quarterly total is $308.6M
  • What Is IDEXX Laboratories’s Book Value Per Share?
    Book value per share is 19.72

Is IDEXX Laboratories Cash Flow Positive?

  • What Is IDXX Cash Flow From Operations?
    Cash flow from operations (TTM) is $916.8M
  • What Is IDEXX Laboratories’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$747.1M
  • What Is IDEXX Laboratories’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$197.7M

IDEXX Laboratories Return On Invested Capital

  • Is Management Doing A Good Job?
    IDXX return on invested capital is 35.27%
  • What Is IDEXX Laboratories Return On Assets?
    ROA measures how assets are converting to revenues and is 26.31%
  • What Is IDXX Return On Equity?
    ROE is a measure of profitability and is 57.37%

IDEXX Laboratories Earnings Date & Stock Price

IDEXX Laboratories Competitors

  • Who Are IDEXX Laboratories's Competitors?
    Below is a list of companies who compete with IDEXX Laboratories or are related in some way:
    • Agilent Technologies Inc (A)
    • Baxter International Inc (BAX)
    • Bio-Rad Laboratories Inc (BIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • West Pharmaceutical Services Inc (WST)

IDEXX Laboratories Dividend Yield

IDEXX Laboratories Analyst Estimates

YoY Growth Past Surprise
EPS: 10.67% 4.26%
Revenue: 6.56% -0.55%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 491.26
Upside from Last Price: 17.73%

Major Shareholders

  • How many IDXX shares are owned by institutional investors?
    115.5M IDXX shares are owned by institutional investors
  • How many IDXX shares are owned by insiders?
    716.5K IDXX shares are owned by insiders